<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0002140685-26-000001</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002140685</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>common stock, par value $0.0001</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>07/13/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001566044</issuerCik>
        <issuerName>VYNE Therapeutics Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>92941V308</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>685 ROUTE 202/206 N., SUITE 301</com:street1>
          <com:street2>685 ROUTE 202/206 N., SUITE 301</com:street2>
          <com:city>BRIDGEWATER</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>08807</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Zhang Xiaofan</reportingPersonName>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>VYNE Therapeutics Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>685 ROUTE 202/206 N., SUITE 301, 685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER, NEW JERSEY, 08807.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>zhang xiaofan</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Rm1607, tower 3, central residence, 1038 Huashan Road, Shanghai</principalBusinessOfficeOrResidenceAddress>
        <citizenship>hong kong</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>4595118</amountBeneficiallyOwned>
        <classPercent>13.8%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>4595118</solePowerOrDirectToVote>
          <solePowerOrDirectToDispose>4595118</solePowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Zhang Xiaofan</reportingPersonName>
      <signatureDetails>
        <signature>zhang xiaofan</signature>
        <title>Mr</title>
        <date>07/14/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
